Factors influencing the response to specific immunotherapy for asthma in children aged 5-16 years

Pediatrics International

Volumn 55, Issue 6, 2013, Pages 680-684

  Peng, Wansheng ^a   Liu, Enmei ^b  

^a BENGBU MEDICAL COLLEGE   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

asthma; children; prognosis; specific immunotherapy

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; ALLERGEN;

ADOLESCENT; ALLERGEN SPECIFIC IMMUNOTHERAPY; ARTICLE; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; CHILD; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; FAMILY HISTORY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MILD INTERMITTENT ASTHMA; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; ONSET AGE; PASSIVE SMOKING; PRIORITY JOURNAL; SEVERE PERSISTENT ASTHMA; TREATMENT RESPONSE; WHEEZING; DESENSITIZATION; IMMUNOLOGY; PRESCHOOL CHILD; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; ALLERGENS; ASTHMA; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; PROGNOSIS; TREATMENT OUTCOME;

EID: 84890556984     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12175     Document Type: Article

References (33)

1. WHO Position Paper. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. J. Allergy 1998; 44: 6-42.
2. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2)LEN and AllerGen). Allergy 2008; 63 (Suppl. 86): 8-160.
3. Calderõn MA, Casale TB, Togias A, et al. Allergen-specific immunotherapy for respiratory allergies: From meta-analysis to registration and beyond. J. Allergy Clin. Immunol. 2011; 127: 30-38.
4. Compalati E, Penaqos M, Tarantini F, et al. Specific immunotherapy for respiratory allergy: State of the art according to current meta analysis. Ann. Allergy Asthma Immunol. 2009; 102: 22-28.
5. Peng WS, Yang XQ, Liu EM, et al. Meta-analysis of sublingual immunotherapy with mite allergen for children asthma. Chin. J. Evid. Based Pediatr. 2009; 4: 29-38.
6. Demoly P, Calderon MA,. Dosing and efficacy in specific immunotherapy. Allergy 2011; 66 (Suppl. 95): 38-40.
7. Haugaard L, Dahl R, Jacobsen L,. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effects. J. Allergy Clin. Immunol. 1993; 91: 709-722.
8. Adkinson NF Jr, Eggleston PA, Eney D, et al. A controlled trial of immunotherapy for asthma in allergic children. N. Engl. J. Med. 1997; 336: 324-331.
9. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention: NHLBI/WHO Workshop Report. National Institute of Health, Bethesda, MD, 2006.
10. Dilorenzo G, Mansueto P, Pacor ML, et al. Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. J. Allergy Clin. Immunol. 2009; 123: 1103-1110.
11. Dreborg S,. Histamine reactivity of the skin. J. Allergy 2001; 56: 359-364.
12. Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. Allergy 2007; 62: 317-324.
13. Bousquet J, Van Cauwenberge P,. A critical appraisal of " 'evidence-based medicine' " in allergy and asthma. Allergy 2004; 59 (Suppl. 78): 12-20.
14. Cox L, Cohn JR,. Duration of allergen immunotherapy in respiratory allergy: When is enough, enough. Ann. Allergy Asthma Immunol. 2007; 98: 416-426.
15. Karakoc GB, Yilmaz M, Altintaş DU, Kendirli SG,. Can serum specific IgE/total IgE ratio predict clinical response to allergen specific immunotherapy in children monosensitized to house dust mite? J. Allergy (Cairo) 2012; 2012: 694094.
16. Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation. J. Allergy Clin. Immunol. 2004; 113: 101-108.
17. Arbes SJ Jr, Gergen PJ, Vaughn B, et al. Asthma cases attributable to atopy results from the Third National Health and Nutrition Examination Survey. J. Allergy Clin. Immunol. 2007; 120: 1139-1145.
18. Romanet-Manent S, Charpin D, Magnan A, et al. Allergic vs nonallergic asthma: What makes the difference? J. Allergy 2002; 57: 607-613.
19. Novak N, Bieber T,. Allergic and nonallergic forms of atopic diseases. J. Allergy Clin. Immunol. 2003; 112: 252-262.
20. Borish L, Culp JA,. Asthma: A syndrome composed of heterogeneous diseases. J. Ann. Allergy Asthma Immunol. 2008; 101: 1-8. quiz 8-11: 50.
21. MacDowell AL, Bacharier LB,. Infectious triggers of asthma. J. Immunol. Allergy Clin. North Am. 2005; 25: 45-66.
22. Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N. Engl. J. Med. 2007; 357: 1487-1495.
23. Kraft M, Cassell GH, Pak J, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: Effect of clarithromycin. Chest 2002; 121: 1782-1788.
24. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N. Engl. J. Med. 1995; 332: 133-138.
25. Handoyo S, Rosenwasser LJ,. Asthma phenotypes. J. Curr. Allergy Asthma Rep. 2009; 9: 439-445.
26. Dolovich J, Hargreave FE,. The asthma syndrome: Inciters, inducers and host characteristics. Thorax 1981; 36: 641-644.
27. Hargreave FE, Dolovich J, O'Byrne PM, Ramsdale EH, Daniel EE,. The origin of airway hyperresponsiveness. J. Allergy Clin. Immunol. 1986; 78: 825-832.
28. An SS, Bai TR, Bates JH, et al. Airway smooth muscle dynamics: A common pathway of airway obstruction in asthma. Eur. Respir. J. 2007; 29: 834-860.
29. Halayko AJ, Tran T, Ji SY, et al. Airway smooth muscle phenotype and function: Interactions with current asthma therapies. Curr. Drug Targets 2006; 7: 525-540.
30. Panettieri RA Jr,. Airway smooth muscle: An immunomodulatory cell. J. Allergy Clin. Immunol. 2002; 110 (6 Suppl): 269-274.
31. Meurs H, Gosens R, Zaagsma J,. Airway hyperresponsiveness in asthma: Lessons from in vitro model systems and animal models. Eur. Respir. J. 2008; 32: 487-502.
32. Cockcroft DW, Davis BE,. Mechanisms of airway hyperresponsiveness. J. Allergy Clin. Immunol. 2006; 118: 551-561.
33. Platts-Mills TA,. The role of immunoglobulin E in allergy and asthma. Am. J. Respir. Crit. Care Med. 2001; 164: S1-5.